227 related articles for article (PubMed ID: 28185879)
1. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation.
Capo V; Castiello MC; Fontana E; Penna S; Bosticardo M; Draghici E; Poliani LP; Sergi Sergi L; Rigoni R; Cassani B; Zanussi M; Carrera P; Uva P; Dobbs K; Sacchetti N; Notarangelo LD; van Til NP; Wagemaker G; Villa A
J Allergy Clin Immunol; 2018 Sep; 142(3):928-941.e8. PubMed ID: 29241731
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
5. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.
Volk T; Pannicke U; Reisli I; Bulashevska A; Ritter J; Björkman A; Schäffer AA; Fliegauf M; Sayar EH; Salzer U; Fisch P; Pfeifer D; Di Virgilio M; Cao H; Yang F; Zimmermann K; Keles S; Caliskaner Z; Güner SÜ; Schindler D; Hammarström L; Rizzi M; Hummel M; Pan-Hammarström Q; Schwarz K; Grimbacher B
Hum Mol Genet; 2015 Dec; 24(25):7361-72. PubMed ID: 26476407
[TBL] [Abstract][Full Text] [Related]
6. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
[TBL] [Abstract][Full Text] [Related]
7. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
Mou W; Gao L; He J; Yin J; Xu B; Gui J
Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
[TBL] [Abstract][Full Text] [Related]
10. Novel spontaneous deletion of artemis exons 10 and 11 in mice leads to T- and B-cell deficiency.
Barthels C; Puchałka J; Racek T; Klein C; Brocker T
PLoS One; 2013; 8(9):e74838. PubMed ID: 24069355
[TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficiency in stimulator of interferon genes (STING) V154M/wild-type mice.
Bouis D; Kirstetter P; Arbogast F; Lamon D; Delgado V; Jung S; Ebel C; Jacobs H; Knapp AM; Jeremiah N; Belot A; Martin T; Crow YJ; André-Schmutz I; Korganow AS; Rieux-Laucat F; Soulas-Sprauel P
J Allergy Clin Immunol; 2019 Feb; 143(2):712-725.e5. PubMed ID: 29800647
[TBL] [Abstract][Full Text] [Related]
12. Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration.
Maina V; Marrella V; Mantero S; Cassani B; Fontana E; Anselmo A; Del Prete A; Sozzani S; Vezzoni P; Poliani PL; Villa A
J Leukoc Biol; 2013 Dec; 94(6):1221-30. PubMed ID: 24052573
[TBL] [Abstract][Full Text] [Related]
13. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
[TBL] [Abstract][Full Text] [Related]
14. Unusual phenotype in patients with a hypomorphic mutation in the DCLRE1C gene: IgG hypergammaglobulinemia with IgA and IgE deficiency.
Nahum A; Somech R; Shubinsky G; Levy J; Broides A
Clin Immunol; 2020 Apr; 213():108366. PubMed ID: 32092471
[TBL] [Abstract][Full Text] [Related]
15. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
[TBL] [Abstract][Full Text] [Related]
16. Omenn syndrome: inflammation in leaky severe combined immunodeficiency.
Villa A; Notarangelo LD; Roifman CM
J Allergy Clin Immunol; 2008 Dec; 122(6):1082-6. PubMed ID: 18992930
[TBL] [Abstract][Full Text] [Related]
17. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome.
Rigoni R; Fontana E; Dobbs K; Marrella V; Taverniti V; Maina V; Facoetti A; D'Amico G; Al-Herz W; Cruz-Munoz ME; Schuetz C; Gennery AR; Garabedian EK; Giliani S; Draper D; Dbaibo G; Geha RS; Meyts I; Tousseyn T; Neven B; Moshous D; Fischer A; Schulz A; Finocchi A; Kuhns DB; Fink DL; Lionakis MS; Swamydas M; Guglielmetti S; Alejo J; Myles IA; Pittaluga S; Notarangelo LD; Villa A; Cassani B
J Allergy Clin Immunol; 2020 Nov; 146(5):1165-1179.e11. PubMed ID: 32311393
[TBL] [Abstract][Full Text] [Related]
20. The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.
Lee PP; Woodbine L; Gilmour KC; Bibi S; Cale CM; Amrolia PJ; Veys PA; Davies EG; Jeggo PA; Jones A
Clin Immunol; 2013 Dec; 149(3):464-74. PubMed ID: 24230999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
